PHILADELPHIA — (March 21, 2025) — Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., in collaboration with scientists in the laboratory of Norbert Pardi, Ph.D., at the University of Pennsylvania Perelman School of Medicine and at the…
The Wistar Institute has established two new internal funding awards to advance the careers of promising Wistar scientists making an impact in biomedical research.
In her role as dean of biomedical studies at The Wistar Institute, Dr. Kristy Shuda McGuire uses her love of science and teaching to nurture future scientists, from high school students to adults.
PHILADELPHIA — (March 10, 2025) — The Wistar Institute’s Paul M. Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers caused by Epstein-Barr Virus (EBV), in the paper, “USP7 inhibitors destabilize EBNA1 and suppr…
PHILADELPHIA — (February 28, 2025) —The Wistar Institute welcomes its newest faculty member, Colby Maldini, Ph.D., who joins Wistar’s HIV Cure and Viral Diseases Center as a Caspar Wistar Fellow.
Dr. Maldini comes to Wistar with expertise in appl…
Roma Maraj-Owen, director of Laboratory Operations and Environmental Health & Safety, leads the Environmental Health & Safety Department here at Wistar. Roma oversees a team responsible for safety & compliance. Her team has the important…
PHILADELPHIA — (February 17th, 2025) — Researchers at The Wistar Institute’s HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the viru…
As part of the Distinguished Lectures in Cancer Research series, Jennifer Heemstra, Ph.D., presented to Wistar faculty and trainees on her scientific research and a professional passion of hers, the importance of mentorship in research. Dr. Heemstra…
Anneliese Faustino, Ph.D., recently joined The Wistar Institute as the associate managing director of the Proteomics Facility. She is also an artist who uses art to advance her science. Here she discusses why proteomic analysis is so critical to mod…
PHILADELPHIA — (February 5, 2025) —The lab of The Wistar Institute’s Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. The team published their findings in the paper, “Selec…
